Non-Steroidal Anti-Inflammatory Drugs Market Overview

Table of Contents

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Overview

The global non-steroidal anti-inflammatory drugs (NSAIDs) market is projected to expand from USD 21.01 billion in 2023 to approximately USD 33.55 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.0% from 2024 to 2032.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5132

Report Highlights:

Arthritis, a common inflammatory bone condition, continues to be the leading focus in the NSAIDs market, holding 38% of the market share in 2023.
Oral administration is the most popular method, accounting for 56% of the market share in 2023, mainly because it’s convenient for patients.
Retail pharmacies dominate the distribution of NSAIDs, capturing 46% of the market share in 2023.
North America is the largest market for NSAIDs, leading the global industry.

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Companies

Key players in the non-steroidal anti-inflammatory drugs (NSAIDs) market include:

Pfizer Inc.: A global leader in the pharmaceutical industry, Pfizer manufactures a variety of NSAIDs for pain and inflammation management.
Merck & Co., Inc.: Merck offers innovative NSAID solutions and has a strong presence in the global market with several pain relief products.
Novartis AG: A multinational pharmaceutical company, Novartis provides NSAID treatments for chronic and acute inflammatory conditions.
GlaxoSmithKline Plc: Known for its broad portfolio, GSK is involved in the development and marketing of NSAIDs for various therapeutic applications.
Johnson & Johnson Services Inc.: With a focus on pain management, J&J is a key player in the NSAID market, offering over-the-counter and prescription solutions.
Bayer AG: A leading company in the healthcare sector, Bayer produces NSAIDs for the treatment of pain, fever, and inflammation.
Dr. Reddy’s Laboratories Ltd.: Dr. Reddy’s is a prominent generic drug manufacturer that supplies affordable NSAID options globally.
Viatris Inc.: Viatris provides a range of NSAIDs, with a focus on accessibility and affordability in the global market.
AstraZeneca: AstraZeneca is involved in the development of NSAIDs for pain relief, particularly in the context of arthritis and other chronic conditions.
Abbott Laboratories: Abbott offers NSAID products targeted at managing pain and inflammation, with a strong focus on both prescription and over-the-counter formulations.

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/non-steroidal-anti-inflammatory-drugs-market-sizing

Access exclusive insight now @ https://www.towardshealthcare.com/price/5132

We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

6 months ago

Elena Morales

Elena Morales is a healthcare industry expert working at Healthcare Web Wire Consulting Firm, a subsidiary of Towards Healthcare. With her excellent knowledge of the field, Elena helps clients optimize their operations and navigate healthcare regulations. She's dedicated to staying updated on industry trends to make a positive impact on patient care. Elena is known for her professionalism and commitment to excellence, making her a valuable asset to any team.